Healthcare

InteliCare Holdings Ltd (ASX:ICR) shares advanced 11.11% to AUD 0.020 during the morning session on 28 July 2026 after the company announced an expansion of its commercial agreement with Hardi Aged Care, marking further progress in scaling its AI-driven aged care technology platform.

dorsaVi Limited (ASX:DVL) shares climbed 7.14% to AUD 0.030 during the morning session on 28 July 2026 after the company announced the commercial launch of Sensor v6.5, a new intelligent wearable sensor designed to deliver real-time movement analysis and feedback directly on the device.

Telix Pharmaceuticals Limited (ASX: TLX) continues to expand its radiopharmaceutical business as commercial revenue growth is accompanied by ongoing investment in clinical development programs.

OncoSil Medical Ltd (ASX: OSL) is advancing regulatory and commercial activities for its OncoSil device, a targeted internal radiotherapy treatment designed to deliver radiation directly into tumours.

Clinuvel told the market it had initiated a reorganisation to refocus on the United States market, effective from January 2027. The plan involves moving headquarters and key functions overseas, reducing global headcount by roughly 10 to 20 per cent, and directing resources toward its …

Mayne pursued the matter through the New South Wales Supreme Court after the buyer purported to terminate the agreement, alleging a material adverse change. The court found in Mayne's favour and ordered the buyer to pay Mayne's litigation costs. The Australian Treasurer separately blocked …

Pro Medicus Ltd (ASX: PME) closed on 27 July 2026 at $162.24, recording a gain of 1.51% or $2.42 during the trading session. The movement occurred during a positive session for Australian equities, with the S&P/ASX 200 (ASX:XJO) advancing 1.39% to 8,894.00 points.